Aciclovir Mylan

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Aciclovir sodium 314.4 mg equivalent to Aciclovir 250 mg
Available from:
Viatris Limited
INN (International Name):
Aciclovir sodium 314.4 mg (equivalent to Aciclovir 250 mg)
Dosage:
250 mg
Pharmaceutical form:
Powder for infusion
Composition:
Active: Aciclovir sodium 314.4 mg equivalent to Aciclovir 250 mg
Prescription type:
Prescription
Manufactured by:
Sequent Scientific Limited
Therapeutic indications:
Aciclovir is indicated for the treatment of Herpes simplex infections. Aciclovir is indicated for the prophylaxis of Herpes simplex infections in immune-compromised patients. Aciclovir is indicated for the treatment of Varicella zoster infections. Aciclovir is indicated for the treatment of Herpes simplex infections in the neonate. Aciclovir infusion formulations are indicated for the prophylaxis of CMV infection in bone marrow transplant recipients. It has been shown that high dose intravenous aciclovir reduces the incidence and delays the onset of CMV infection. When high dose intravenous aciclovir is followed by 6 months treatment with high dose oral aciclovir (see prescribing information for oral aciclovir) mortality and the incidence of viraemia are also reduced.
Product summary:
Package - Contents - Shelf Life: Vial, glass, 10 mL Type 1 flint tubular glass vial with rubber closure and aluminium seal - 5 dose units - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-9655
Authorization date:
2014-11-04

Similar products

Search alerts related to this product

Share this information